Abstract:BACKGROUND Rocuronium is a newer non-depolarising muscle relaxant with faster onset of action than other non-depolarising muscle relaxants that could be an alternative to succinylcholine in rapid sequence intubation where succinylcholine is contraindicated. Based on onset of action, 0.9-1.2 mg/kg dose of rocuronium may be necessary as an alternative to succinylcholine at the cost of increased clinical duration. In this study, 0.6 mg/kg rocuronium with priming was compared against a single intubating dose of 0.… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.